Literature DB >> 22206817

Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT₇ receptors.

Ahmet Dogrul1, Melik Seyrek, Emin Ozgur Akgul, Tuncer Cayci, Serdar Kahraman, Hayrunnisa Bolay.   

Abstract

Although some studies have shown the essential role of descending serotonergic pathways and spinal 5-HT(1A), 5-HT(2A), or 5-HT(3) receptors in the antinociceptive effects of paracetamol, other studies have presented conflicting results, and the particular subtype of spinal 5-HT receptors involved in paracetamol-induced analgesia remains to be clarified. Recent studies have demonstrated the importance of spinal 5-HT(7) receptors in descending serotonergic pain inhibitory pathways. In this study, we investigated the role of descending serotonergic pathways and spinal 5-HT(7) receptors compared with 5-HT(3) and 5-HT(2A) receptors in the antinociceptive and antihyperalgesic effects of paracetamol. Tail-flick, hot plate and plantar incision tests were used to determine nociception in male BALB/c mice. Lesion of serotonergic bulbospinal pathways was performed by intrathecal (i.th.) injection of 5,7-dihydroxytryptamine (5,7-DHT), and spinal 5-HT levels were measured by HPLC. To evaluate the particular subtypes of the spinal 5-HT receptors, the selective 5-HT(7), 5-HT(3) and 5-HT(2A) receptor antagonists SB 269970, ondansetron and ketanserin, respectively, were given i.th. after oral administration of paracetamol. Oral paracetamol (200, 400 and 600 mg/kg) elicits dose-dependent antinociceptive and antihyperalgesic effects. I.th. pretreatment with 5,7-DHT (50 μg) sharply reduced 5-HT levels in the spinal cord. Depletion of spinal 5-HT totally abolished the antinociceptive and antihyperalgesic effects of paracetamol. I.th. injection of SB 2669970 (10 μg) blocked the antinociceptive and antihyperalgesic effects of paracetamol, but ondansetron and ketanserin (10 μg) did not. Our findings suggest that systemic administration of paracetamol may activate descending serotonergic pathways and spinal 5-HT(7) receptors to produce a central antinociceptive and antihyperalgesic effects.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22206817     DOI: 10.1016/j.ejphar.2011.12.016

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Enhanced analgesic effects of nefopam in combination with acetaminophen in rodents.

Authors:  Qian Li; Quankun Zhuang; Yaru Gu; Cailing Dai; Xiaoxiao Gao; Xiaomin Wang; Huimin Wen; Xin Li; Yuyang Zhang
Journal:  Biomed Rep       Date:  2017-12-18

Review 2.  The Contribution of Serotonergic Receptors and Nitric Oxide Systems in the Analgesic Effect of Acetaminophen: An Overview of the Last Decade.

Authors:  Yeşim Hamurtekin; Ammar Nouilati; Cansu Demirbatir; Emre Hamurtekin
Journal:  Turk J Pharm Sci       Date:  2020-02-19

3.  Paracetamol is a centrally acting analgesic using mechanisms located in the periaqueductal grey.

Authors:  David André Barrière; Fawzi Boumezbeur; Romain Dalmann; Roberto Cadeddu; Damien Richard; Jérémy Pinguet; Laurence Daulhac; Philippe Sarret; Kevin Whittingstall; Matthieu Keller; Sébastien Mériaux; Alain Eschalier; Christophe Mallet
Journal:  Br J Pharmacol       Date:  2020-01-22       Impact factor: 8.739

Review 4.  Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action.

Authors:  Samir S Ayoub
Journal:  Temperature (Austin)       Date:  2021-03-16

5.  RI75, a curcumin analogue, inhibits tumor necrosis factor-α and interleukin-6 production and exhibits antiallodynic and antiedematogenic activities in mice.

Authors:  Sarah O A M Costa; Ianny B Rodrigues; Alysson V Braga; Bárbara C M Barbosa; Roger R L Silva; Felipe F Rodrigues; Ivo S F Melo; Marcela Í Morais; Brenda F M Castro; Armando S Cunha Júnior; Vinícius G Maltarollo; Renata B Oliveira; Márcio M Coelho; Renes R Machado
Journal:  Inflammopharmacology       Date:  2022-01-30       Impact factor: 4.473

6.  Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor.

Authors:  Anat Levit Kaplan; Ryan T Strachan; Joao M Braz; Veronica Craik; Samuel Slocum; Thomas Mangano; Vanessa Amabo; Henry O'Donnell; Parnian Lak; Allan I Basbaum; Bryan L Roth; Brian K Shoichet
Journal:  J Med Chem       Date:  2022-02-23       Impact factor: 8.039

7.  Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization.

Authors:  Daiany P B da Silva; Iziara F Florentino; Dayane M da Silva; Roberta C Lino; Carina S Cardoso; Lorrane K S Moreira; Géssica A Vasconcelos; Daniela C Vinhal; Anna C D Cardoso; Bianca Villavicencio; Hugo Verli; Boniek G Vaz; Luciano M Lião; Luiz C da Cunha; Ricardo Menegatti; Elson A Costa
Journal:  Inflammopharmacology       Date:  2018-07-23       Impact factor: 4.473

Review 8.  Neonatal pain.

Authors:  Suellen M Walker
Journal:  Paediatr Anaesth       Date:  2013-11-13       Impact factor: 2.556

9.  Effect of drugs modulating serotonergic system on the analgesic action of paracetamol in mice.

Authors:  Yogita S Karandikar; Peeyush Belsare; Aditi Panditrao
Journal:  Indian J Pharmacol       Date:  2016 May-Jun       Impact factor: 1.200

Review 10.  Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?

Authors:  Christopher J Esh; Bryna C R Chrismas; Alexis R Mauger; Lee Taylor
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.